[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CRVS":3,"homepage-market-summary":30,"stock-news-CRVS":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CRVS","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Corvus Pharmaceuticals, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.","37","South San Francisco, CA",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},10.9,11.11,10.64,10.93,-0.03,-0.27,1347800.876701,16069,10.8918,26.95,6.39,1786518.946219848,21.9,2648,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},9,[175,181,187,193,199,204,210,216,221],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"CRVS Stock Surges 10%, Hits 50-DMA For First Time In A Month – Here’s Why Goldman Sachs Sees A 166% Upside - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPSUIyQVl4SmliNjRUUWc1MEYyclhQTFBqcWFJZlptV1Z4d01sSUtHZmgxMWNFNXd4dTN2V0t6eGR0ZndQeEh4QXE4UnVrWFlFRGZ2aEdKekwzOTlxQ0VTeE5NcnlvR0phZ1I2dl8tTnlfcFhtbWhIUVlyOFlTRmM1QTlOSXJyay1VWGhvOVJYNk85UEZoQlBQMHVMalpzb1k4Y0F3czhpWk1LRVNRUkIzeDMtZ19fc3hpT1dBTg?oc=5","Sun, 27 Sep 2026 00:39:51 GMT","CRVS Stock Surges 10%, Hits 50-DMA For First Time In A Month – Here’s Why Goldman Sachs Sees A 166% Upside Stocktwits","Stocktwits",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"One drug is now in trials for four conditions, including a skin disease. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOUnU5dUZ3X2ZHbmdxVlZrSlREUkRxdGI5OTh1eURjbXF1RU9GaEg2LTVoeTRTYUNsYzN1UnVyNlU3MThvNTliRkwzNFRLbjQ4RWx5Ymdsbk9qRlc1YVNaZDd1VzA2TDU3NFBZYzY4SlY0UTRnY0lZeGlSSkVkbnVjVVdfTlZHeFlrZ2xkczJzcGtldGs4STk4RFBFYWhybmdGdU1CWGZSM1BuUXhQMGt5dGl3VGpBZ3BWRnYw?oc=5","Wed, 30 Sep 2026 20:05:00 GMT","One drug is now in trials for four conditions, including a skin disease. Stock Titan","Stock Titan",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Corvus Pharmaceuticals (CRVS) Faces A Valuation Test, Is The Upside Already Priced In? - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxNVlVvMTZMT0hzZ1VKeWtOWkR0S25IcVdiYWhTSG5kNmZMLU9fczRWUDJwZEJUYlkwZ1B2WmhnX3ZSVE5PSmJlOWFqTkVCT20yd083NjdndXJUWDhSRm1LVU5XZm52Wm85V3REMjZoUmY5OUNfWXNMZHZUel9iMHBPSW5XTFhDYXQxWTY5eVVmWERXM1dxcUlZ?oc=5","Fri, 25 Sep 2026 14:09:52 GMT","Corvus Pharmaceuticals (CRVS) Faces A Valuation Test, Is The Upside Already Priced In? Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Trading the Move, Not the Narrative: (CRVS) Edition - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxPM3UwZUFlcTBScDdVallTQU5vWjdoY2JCdUNMWGVlRWhYWTIzNlZreENHV0g1M3Ryb2ltWUc5bUtQNlRlSWJ0NENQMnVBMUNVUWsyWmNIVWRnWk1sc0o1RDE2WDRVdTdHSC1CMGZvVWMySGR3ckNiUGFoelFrT2JaRnlDeVVFUW96VmtvRHpCc1QwUjdFWHgyOFZHaWJlV0Y1SGZGTEtXQkpvUnotUnJuSkx3RkZLSGl6bDRyOEUycG8wLTB1bkFqTmxR?oc=5","Sun, 27 Sep 2026 14:20:02 GMT","Trading the Move, Not the Narrative: (CRVS) Edition Stock Traders Daily","Stock Traders Daily",{"title":200,"link":201,"pubDate":202,"description":203,"source":192},"CRVS Apr 2027 12.000 put (CRVS270416P00012000) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE5lUmtxQmFkOTFNazZHeV9SR2VJZGduNzF5OTMzTEpkRTFnVm04Rm53MFRzaC1fRXgwYlJYcnNOVFh3WTY1M1VmcHo0RlhwNWNpaC1PcEhlS1Nsd2lOdy0xOG1QUjRzcUlaX00tcUlR?oc=5","Mon, 28 Sep 2026 00:28:31 GMT","CRVS Apr 2027 12.000 put (CRVS270416P00012000) Interactive Stock Chart - Yahoo Finance Yahoo! Finance Canada",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"Corvus begins phase 1b trial of soquelitinib for skin disease By Investing.com - in.investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQRjFCTkQ5SGE4LWVpdGRrNXVkVFZwa3k2ZlJKalZJV3pIYUQwakUtZUNCeFMyaC13TkdGaTlWalRIZmpVakxxeVA3dWh4Wm1faFpNWXl4b01nU0lVdE9Ba2NXUjVmYmRwVTdvVUl1eEU1WUF3QkV4aF9JZEN2c3J1ekt1M0pjZFI0dzY4UDl6cDFKTTdRQUp3V0xkTXp6ZmlTckFBa293RHJXM1M5YWZNSHRlX2NaYUdEVVJsaFhENA?oc=5","Wed, 30 Sep 2026 21:14:58 GMT","Corvus begins phase 1b trial of soquelitinib for skin disease By Investing.com in.investing.com","in.investing.com",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"CRVS270115C00011000 Interactive Stock Chart | CRVS Jan 2027 11.000 call Stock - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTE44ZzlMcHNEZm52YU9PZnJJdDNxQndXNVNXYTlfVVFJZ3Nlei03OVZiMVNKcy1zZXdUeEI3ZUpPR1RoUkdPNUs5SFNJVWJvVzd3c1F3TXRxbHllQlo0ekI1bg?oc=5","Thu, 01 Oct 2026 08:07:50 GMT","CRVS270115C00011000 Interactive Stock Chart | CRVS Jan 2027 11.000 call Stock Yahoo Finance","Yahoo Finance",{"title":217,"link":218,"pubDate":219,"description":220,"source":192},"CRVS270416C00020000 Interactive Stock Chart | CRVS Apr 2027 20.000 call Stock - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZEFVX3lxTE03UnNkS21pZW16bi1wMFZxdW9jUHI4eEpHZWxOSXFla0RoN3E1TnN3VG9BVW1Nb3RTVTBmMUJOY2dyYm9PaUpkUXY0TkZOSjBZTzdueDdIdy1CbnNUSjRpSEtzbWc?oc=5","Sat, 03 Oct 2026 17:33:57 GMT","CRVS270416C00020000 Interactive Stock Chart | CRVS Apr 2027 20.000 call Stock Yahoo! Finance Canada",{"title":222,"link":223,"pubDate":224,"description":225,"source":215},"Korsana Biosciences (KRSA) At $31.20 Leaves Valuation Questions On A Sharp 2026 Run - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxOWkpFTnpXX1pIRlNNT2RUSGpzYlF4b1RzWGw4SkRGYUdQS0FDMlVTZXQ1NHRyM2tNMU50ZGR6dWxKOW5YWFg0WXdFQk4wU3FzdFVHeFEyLVBIcHBtRm9SUFN0TVl4OUozMG9RaWQxMkVBTTNHQkNxREFkMURQazBiWTJmcXgxUzNCOVdhaTdJdkUtcFdYX3c?oc=5","Fri, 02 Oct 2026 12:06:31 GMT","Korsana Biosciences (KRSA) At $31.20 Leaves Valuation Questions On A Sharp 2026 Run Yahoo Finance"]